These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 1420496

  • 1. Effect of erythropoietin in continuous ambulatory peritoneal dialysis patients: comparison between intravenous and intraperitoneal administration.
    Nasu T, Mitui H, Shinohara Y, Hayashida S, Ohtuka H.
    Perit Dial Int; 1992; 12(4):373-7. PubMed ID: 1420496
    [Abstract] [Full Text] [Related]

  • 2. Intraperitoneal administration of recombinant human erythropoietin.
    Frenken LA, Struijk DG, Coppens PJ, Tiggeler RG, Krediet RT, Koene RA.
    Perit Dial Int; 1992; 12(4):378-83. PubMed ID: 1420497
    [Abstract] [Full Text] [Related]

  • 3. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF, Law CB, Ting SM, Li P, Lai KN.
    Clin Nephrol; 1991 Nov; 36(5):246-51. PubMed ID: 1752075
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy of once weekly erythropoietin therapy in children on continuous ambulatory peritoneal dialysis.
    Hisano S, Kaku Y, Ueda K, Onoyama K.
    Acta Paediatr Jpn; 1991 Aug; 33(4):450-4. PubMed ID: 1792903
    [Abstract] [Full Text] [Related]

  • 7. Low-dose erythropoietin is effective and safe in children on continuous ambulatory peritoneal dialysis.
    Yalçinkaya F, Tümer N, Cakar N, Ozkaya N.
    Pediatr Nephrol; 1997 Jun; 11(3):350-2. PubMed ID: 9203190
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of intramuscular versus subcutaneous erythropoietin for the treatment of anemia in CAPD patients.
    Abreo K, Lubom JA, Collier L, Fleming D, Work J.
    Adv Perit Dial; 1994 Jun; 10():124-8. PubMed ID: 7999809
    [Abstract] [Full Text] [Related]

  • 13. Anemia of chronic renal failure: treatment with erythropoietin.
    Navarro M, Alonso A, Avilla JM, Espinosa L.
    Child Nephrol Urol; 1991 Jun; 11(3):146-51. PubMed ID: 1777893
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of subcutaneous and intraperitoneal administration of recombinant human erythropoietin on blood pressure and vasoactive hormones in patients on continuous ambulatory peritoneal dialysis.
    Lai KN, Lui SF, Leung JC, Law E, Nicholls MG.
    Nephron; 1991 Jun; 57(4):394-400. PubMed ID: 1828543
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.